Pancreatic cancer action network - Join us
Clinical Trial
Finder
Retrieving Trials
Retrieving Trials...

Back to Trial Search

Study Of CBP501, Cisplatin, Nivolumab Combinations In Patients With Advanced Pancreatic Cancer

Summary

The purpose of this phase II trial is to evaluate the efficacy and feasibility of four combinations of CBP501, cisplatin, and Nivolumab in patients with advanced pancreatic cancer.

General Information

NCT#: NCT04953962
Study ID: CBP21-01
Trial Phase: Phase II

Trial Sponsor: CanBas Co. Ltd.
Therapies Used in This Trial: Cisplatin, Nivolumab, CBP501

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

View Details

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account?

Request an Account


  • In order to view this information, you need to be signed in as a Health Care Provider.
  • You need to be signed in as a Health Care Provider. Please request an account.
  • In order to view this information, you need to be signed in as a Health Care Provider.
  • In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
  • This information is restricted to validated Health Care Providers.

Eligibility



-------------------------------------------------------------------------------------------

  • In order to view this information, you need to be signed in as a Health Care Provider.
  • You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
  • ------------------------------------------------------------------------------------------------------
  • In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Site Information


Back to Trial Search